Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-24 @ 11:14 PM
NCT ID: NCT03667469
Eligibility Criteria: Inclusion Criteria: * BMI from 30 to 50 kg / m2; * Metabolic syndrome (MetS) with abdominal adiposity if there are at least two components of MetS from the following: Increase in fasting plasma glucose: detected before diabetes (HbA1 = 5.7-6.4 or 3-fold increase in fasting plasma glucose:\> 5.6 mmol / l); or previously diagnosed type 2 diabetes (HbA1\> 6.5, or glucose\> 6.1); Arterial hypertension AD 130 / 85 mmHg or receiving antihypertensive therapy; Increased triglyceride levels\> 1.7 mmol / L or a specific treatment for this disorder; Reduction of high-density lipoproteins (HDL-C) \<1.03 mmol / L in men and less than 1.29 mmol / L in women or receiving treatment for this disorder; * The possibility of treatment for 12 months and the possibility of follow up; * Informed written consent of the patient for randomization and treatment. Exclusion Criteria: * Age is less than 18 or more than 65 years; * BMI less than 30 kg / m2 and more than 50 kg / m2; * Drug addiction and alcohol consumption; * Complete immobilization of the patient (paresis / paralysis); * Presence in the anamnesis bariatric procedures; * Insulin-dependent diabetes; * Mental disorders or taking antidepressants; * Socially vulnerable categories (according to ethical principles); * Patients who do not understand the purpose of the study; * Lack of informed written consent.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT03667469
Study Brief:
Protocol Section: NCT03667469